Stocktoria
iRhythm Holdings, Inc. IRTC
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-10-20
iRhythm Holdings, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $747.1M | $591.8M | $492.7M | $410.9M | $322.8M | $265.2M | $214.6M | $147.3M | $99.1M | $64.1M |
| Gross profit | $527.2M | $407.5M | $331.8M | $281.6M | $213.6M | $194.9M | $162.1M | $108.5M | $70.9M | $43.2M |
| R&D expense | — | — | $60.2M | $46.6M | $38.7M | $41.3M | $37.3M | $20.9M | $13.3M | $7.2M |
| SG&A expense | $492.6M | $418.6M | $385.6M | $322.2M | $274.8M | $197.2M | $179.5M | $133.3M | $85.3M | $51.6M |
| Operating income | -$57.4M | -$115.5M | -$125.2M | -$113.8M | -$99.9M | -$43.7M | -$54.8M | -$45.7M | -$27.6M | -$15.6M |
| Interest expense | — | — | $3.6M | $4.1M | $1.2M | $1.5M | $1.6M | $3.1M | $3.4M | $3.2M |
| Income tax | $953,000 | $565,000 | $750,000 | $269,000 | $367,000 | $229,000 | $65,000 | $44,000 | $0 | $0 |
| Net income | -$44.6M | -$113.3M | -$123.4M | -$116.2M | -$101.4M | -$43.8M | -$54.6M | -$50.4M | -$29.7M | -$20.9M |
| EPS (diluted) | $-1.39 | $-3.63 | $-4.04 | $-3.88 | $-3.46 | $-1.58 | $-2.16 | — | — | — |
| Operating cash flow | $80.9M | $3.4M | -$50.1M | -$23.0M | -$37.8M | -$13.8M | -$21.9M | -$29.1M | -$14.9M | -$16.7M |
| Free cash flow | $34.5M | -$30.6M | -$90.5M | -$52.8M | -$65.8M | -$27.3M | -$42.3M | -$34.3M | -$18.5M | -$19.4M |
| Cash & equivalents | $236.0M | $419.6M | $36.2M | $78.8M | $127.6M | $88.6M | $20.5M | $20.0M | $8.7M | $51.6M |
| Inventory | $21.6M | $14.0M | $14.0M | $15.2M | $10.3M | $5.3M | $4.0M | $2.1M | $1.7M | $1.4M |
| Total assets | $1.0B | $931.4M | $433.1M | $448.2M | $463.0M | $511.7M | $306.2M | $117.5M | $133.4M | $138.2M |
| Total liabilities | $867.3M | $840.5M | $223.0M | $208.4M | $183.5M | $170.1M | $170.8M | $65.4M | $54.0M | $45.6M |
| Shareholders' equity | $152.7M | $90.9M | $210.1M | $239.8M | $279.5M | $341.6M | $135.4M | $52.1M | $79.3M | $93.0M |
Growth · year-over-year · Revenue CAGR 31.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +26.2% | +20.1% | +19.9% | +27.3% | +21.7% | +23.6% | +45.7% | +48.6% | +54.7% | +77.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.